Home › Funds › Catalio Capital Management, LP › GPCR
Catalio Capital Management, LP position in GPCR
STRUCTURE THERAPEUTICS INC · Health Care
Catalio Capital Management, LP reported holding 276,550 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$14.8M, representing 2.79% of its reported portfolio and ranking #15 among its reported holdings. Catalio Capital Management, LP has disclosed GPCR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's GPCR position evolved
Catalio Capital Management, LP first disclosed a stake in GPCR in Q4 2024 at 569,395 shares (US$15.4M). The position peaked in Q3 2025 at 651,810 shares, worth US$18.3M. Across 7 filings, Catalio Capital Management, LP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 276,550 shares valued at US$14.8M — an increase of 21,171 shares quarter over quarter.. Notable position changes include a 61% trim in Q4 2025 (shares fell 31% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 569.39K | $15.44M | New |
| Q1 2025 | 704.86K | $12.20M | Add |
| Q2 2025 | 670.58K | $13.91M | Reduce |
| Q3 2025 | 651.81K | $18.25M | Reduce |
| Q4 2025 | 252.90K | $17.59M | Reduce |
| Q1 2026 | 255.38K | $12.31M | Add |
| Q2 2026 | 276.55K | $14.84M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GPCR and 13F data
GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), BVF INC/IL (US$180.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GPCR
- Avoro Capital Advisors LLC 6.56M sh · $351.84M · Q2 2026
- Deep Track Capital, LP 4.74M sh · $254.40M · Q2 2026
- BVF INC/IL 3.37M sh · $180.70M · Q2 2026
- ORBIMED ADVISORS LLC 2.21M sh · $118.58M · Q2 2026
- RTW INVESTMENTS, LP 1.61M sh · $86.27M · Q2 2026
- BAKER BROS. ADVISORS LP 1.43M sh · $76.88M · Q2 2026
- Casdin Capital 1.18M sh · $63.06M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.09M sh · $58.29M · Q2 2026
- Siren, L.L.C. 872.97K sh · $46.85M · Q2 2026
- PACIFIC HEIGHTS ASSET MANAGEMENT LLC 800.00K sh · $42.94M · Q2 2026
- Rock Springs Capital Management LP 640.32K sh · $34.37M · Q2 2026
- Logos Global Management LP 500.00K sh · $26.84M · Q2 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held GPCR?
Catalio Capital Management, LP has disclosed GPCR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Catalio Capital Management, LP's current position in GPCR?
As of Q2 2026, Catalio Capital Management, LP holds 276.55K shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $14.84M, representing 2.79% of its reported portfolio and ranking #15.
Has Catalio Capital Management, LP been buying or selling GPCR?
In the latest 13F filing (Q2 2026), Catalio Capital Management, LP increased its position in GPCR. The position peaked in Q3 2025 at 651.81K shares.
Which other funds hold GPCR?
Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, BVF INC/IL, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.